1. Unusual Presentation of Recurrent Early Stage Endometrial Carcinoma 28 Years after Primary Surgery
- Author
-
Luigi Chiusa, Fronda Gr, Luca Molinaro, A. Franchello, D. Cassine, Sara Galati, S. Silvestri, G. Deiro, Alessia Fiore, and A. Resegotti
- Subjects
medicine.medical_specialty ,Hysterectomy ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,lcsh:Surgery ,Colostomy ,Microsatellite instability ,Colonoscopy ,Case Report ,lcsh:RD1-811 ,medicine.disease ,MLH1 ,Metastasis ,Surgery ,Carcinoma ,medicine ,Pharmacology (medical) ,Stage (cooking) ,business - Abstract
Endometrial carcinoma is the most common neoplasia of female genital tract. The prognosis of early stage disease (FIGO I and FIGO II) is excellent: recurrence after surgery is less than 15%, most of which are reported within 3 years after primary treatment. Herein we report a case of late rectal recurrence from FIGO Ib endometrial adenocarcinoma. Patient had also familiar and personal history of colonic adenocarcinoma and previous findings of microsatellite instability (MSI); molecular analysis evidenced heterozygotic somatic mutation in MLH1 gene. Twenty-eight years after hysterectomy and bilateral salpingoovariectomy, a rectal wall mass was detected during routine colonoscopy. Patients underwent CT scan, pelvic MRI, and rectal EUS with FNA: histopathological and immunohistochemical analysis revealed differentiated carcinoma cells of endometrial origin. No neoadjuvant treatment was planned and low rectal anterior resection with protective colostomy was performed; histology confirmed rectal lesion as metastasis from endometrial carcinoma. Recurrence of early stage endometrial carcinoma after a long period from primary surgery is possible. It is important to keep in mind this possibility in order to set a correct diagnostic and therapeutic algorithm, including preoperative immunohistochemical staining, and to plan a prolonged follow-up program.
- Published
- 2015